The University of Southampton
University of Southampton Institutional Repository

Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors.

Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors.
Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors.
BACKGROUND: Human papillomavirus positive (HPV+) head and neck squamous cell carcinoma (HNSCC) is an emerging disease, representing a distinct clinical and epidemiological entity. Understanding the genetic basis of this specific subtype of cancer could allow therapeutic targeting of affected pathways for a stratified medicine approach. METHODS: Twenty HPV+ and 20 HPV- laser-capture microdissected oropharyngeal carcinomas were used for paired-end sequencing of hybrid-captured DNA, targeting 3,230 exons in 182 genes often mutated in cancer. Copy number alteration (CNA) profiling, Sequenom MassArray sequencing and immunohistochemistry were used to further validate findings. RESULTS: HPV+ and HPV- oropharyngeal carcinomas cluster into two distinct subgroups. TP53 mutations are detected in 100/S checkpoint by CDKN2A/B deletion and/or CCND1 amplification occurs in the majority of HPV- tumors. CONCLUSION: These findings strongly support a causal role for HPV, acting via p53 and RB pathway inhibition, in the pathogenesis of a subset of oropharyngeal cancers and suggest that studies of CDK inhibitors in HPV negative disease may be warranted. Mutation and copy number alteration of PI3 kinase (PI3K) pathway components appears particularly prevalent in HPV+ tumors and assessment of these alterations may aid in the interpretation of current clinical trials of PI3K, AKT and mTOR inhibitors in HNSCC.
1756-994X
Lechner, M
19c72359-7dc0-435c-817a-f67d4956656f
Frampton, G
ffd6d5f3-2547-4b7d-931e-38aa60af4cf5
Fenton, TR
087260ba-f6a1-405a-85df-099d05810a84
Feber, A
cdc62c70-e4c3-4a70-8eff-515a6eaf895b
Palmer, G
12e03c62-3c02-4e1d-a21f-6db21a922969
Jay, A
78312454-2b2b-4be8-bafa-506a2f8829c2
Pillay, N
f4b5ccdc-5825-4797-a1c9-fe9c7f239170
Forster, M
11a9ca2f-4405-4613-9b2f-3c6c1b12785e
Cronin, MT
955d858a-fedb-48cf-9abb-d9f6353ea983
Lipson, D
400d7461-28a8-49f1-a037-f05d695cd8cb
Miller, VA
739fdb08-7b05-4d66-95c3-d9acfe86940c
Brennan, TA
032e8e91-8975-4496-9b37-54210c7264c7
Henderson, S
1f160dd8-a921-4a12-91bb-588a1890c7f3
Vaz, F
ba6841e6-8ce6-4015-a24e-8538df435147
Flynn, P O 8217
1c826578-9504-4899-b6a8-46dc88069551
Kalavrezos, N
318f92d5-6538-4a4e-a550-709775d36b32
Yelenski, R
e034b96a-ac09-4947-a5ed-24242924adb2
Beck, S
67ec6ea3-2aed-415b-894b-55eefb959479
Stephens, PJ
6565a5c4-5cbf-4e35-be4c-ac629c903199
Boshoff, C
7a31a970-ff94-4ea6-b24a-dab87ae08074
Lechner, M
19c72359-7dc0-435c-817a-f67d4956656f
Frampton, G
ffd6d5f3-2547-4b7d-931e-38aa60af4cf5
Fenton, TR
087260ba-f6a1-405a-85df-099d05810a84
Feber, A
cdc62c70-e4c3-4a70-8eff-515a6eaf895b
Palmer, G
12e03c62-3c02-4e1d-a21f-6db21a922969
Jay, A
78312454-2b2b-4be8-bafa-506a2f8829c2
Pillay, N
f4b5ccdc-5825-4797-a1c9-fe9c7f239170
Forster, M
11a9ca2f-4405-4613-9b2f-3c6c1b12785e
Cronin, MT
955d858a-fedb-48cf-9abb-d9f6353ea983
Lipson, D
400d7461-28a8-49f1-a037-f05d695cd8cb
Miller, VA
739fdb08-7b05-4d66-95c3-d9acfe86940c
Brennan, TA
032e8e91-8975-4496-9b37-54210c7264c7
Henderson, S
1f160dd8-a921-4a12-91bb-588a1890c7f3
Vaz, F
ba6841e6-8ce6-4015-a24e-8538df435147
Flynn, P O 8217
1c826578-9504-4899-b6a8-46dc88069551
Kalavrezos, N
318f92d5-6538-4a4e-a550-709775d36b32
Yelenski, R
e034b96a-ac09-4947-a5ed-24242924adb2
Beck, S
67ec6ea3-2aed-415b-894b-55eefb959479
Stephens, PJ
6565a5c4-5cbf-4e35-be4c-ac629c903199
Boshoff, C
7a31a970-ff94-4ea6-b24a-dab87ae08074

Lechner, M, Frampton, G, Fenton, TR, Feber, A, Palmer, G, Jay, A, Pillay, N, Forster, M, Cronin, MT, Lipson, D, Miller, VA, Brennan, TA, Henderson, S, Vaz, F, Flynn, P O 8217, Kalavrezos, N, Yelenski, R, Beck, S, Stephens, PJ and Boshoff, C (2013) Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors. Genome Medicine, 5, [49]. (doi:10.1186/gm453).

Record type: Article

Abstract

BACKGROUND: Human papillomavirus positive (HPV+) head and neck squamous cell carcinoma (HNSCC) is an emerging disease, representing a distinct clinical and epidemiological entity. Understanding the genetic basis of this specific subtype of cancer could allow therapeutic targeting of affected pathways for a stratified medicine approach. METHODS: Twenty HPV+ and 20 HPV- laser-capture microdissected oropharyngeal carcinomas were used for paired-end sequencing of hybrid-captured DNA, targeting 3,230 exons in 182 genes often mutated in cancer. Copy number alteration (CNA) profiling, Sequenom MassArray sequencing and immunohistochemistry were used to further validate findings. RESULTS: HPV+ and HPV- oropharyngeal carcinomas cluster into two distinct subgroups. TP53 mutations are detected in 100/S checkpoint by CDKN2A/B deletion and/or CCND1 amplification occurs in the majority of HPV- tumors. CONCLUSION: These findings strongly support a causal role for HPV, acting via p53 and RB pathway inhibition, in the pathogenesis of a subset of oropharyngeal cancers and suggest that studies of CDK inhibitors in HPV negative disease may be warranted. Mutation and copy number alteration of PI3 kinase (PI3K) pathway components appears particularly prevalent in HPV+ tumors and assessment of these alterations may aid in the interpretation of current clinical trials of PI3K, AKT and mTOR inhibitors in HNSCC.

This record has no associated files available for download.

More information

Accepted/In Press date: 29 May 2013
Published date: 29 May 2013
Additional Information: This work is licensed under the Creative Commons Attribution License, Attribution 3.0 Unported (CC BY 3.0) http://creativecommons.org/licenses/by/3.0/ which permits unrestricted use, distribution, and reproduction in any medium. However, you must attribute the work to the author (but not in any way that suggests that they endorse you or your use of the work).

Identifiers

Local EPrints ID: 453965
URI: http://eprints.soton.ac.uk/id/eprint/453965
ISSN: 1756-994X
PURE UUID: 70ac87b0-7024-43cc-b7c2-019a22cf294b
ORCID for TR Fenton: ORCID iD orcid.org/0000-0002-4737-8233

Catalogue record

Date deposited: 26 Jan 2022 17:51
Last modified: 17 Mar 2024 04:11

Export record

Altmetrics

Contributors

Author: M Lechner
Author: G Frampton
Author: TR Fenton ORCID iD
Author: A Feber
Author: G Palmer
Author: A Jay
Author: N Pillay
Author: M Forster
Author: MT Cronin
Author: D Lipson
Author: VA Miller
Author: TA Brennan
Author: S Henderson
Author: F Vaz
Author: P O 8217 Flynn
Author: N Kalavrezos
Author: R Yelenski
Author: S Beck
Author: PJ Stephens
Author: C Boshoff

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×